摘要
目的:观察辛伐他汀联合参麦治疗高血脂症的临床疗效。方法:168例高血脂症患者随机分为治疗组和对照组,两组均采用常规辛伐他汀治疗,治疗组加用参麦注射液40mL静脉输注,每日1次;4周后测定血浆总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)和高敏C反应蛋白(hs-CRP)。结果:在治疗后第4周,治疗组与对照组相比较,TC、LDL-C和CRP明显下降,HDL-C升高,差异显著,均具有统计学意义(P<0.05)。结论:辛伐他汀联合参麦治疗高血脂效果更明显,可更有效降低hs-CRP水平。
Objective：To evaluate the clinical therapeutic effect of combination simastatin and shenmai in patients with hyperlipidemia.Methods：168 patients with hyperlipidemia were randomly divided into treatment group and control group.All patients were given regular simastatin treatment.In treatment group,40mL shenmai injection,ivgtt,once a day for 4 weeks.TC、HDL-C、LDL-C and CRP were determined after 4 weeks.Results：Comparised treatment group with control group,TC、LDL-C and hs-CRP were decreased,HDL-C was increased,there were significant differences（P〈0.05）.Conclusion：simastatin combinated shenmai was more efffective for hyperlipidemia and decreased hs-CRP in plasma blood.
出处
《实用中西医结合临床》
2010年第6期9-10,共2页
Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
